Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo (Q40614325)
Jump to navigation
Jump to search
scientific article published on November 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo |
scientific article published on November 2003 |
Statements
1 reference
Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo (English)
1 reference
Kosei Hasegawa
1 reference
Atsushi Hongo
1 reference
Hiroyuki Kuramoto
1 reference
Yojiro Nakamura
1 reference
Keiichiro Nakamura
1 reference
Junichi Kodama
1 reference
Yuji Hiramatsu
1 reference
1 November 2003
1 reference
1 reference
63
1 reference
22
1 reference
7834-7839
1 reference
Identifiers
1 reference